Superantigens in dermatology

Journal of the American Academy of Dermatology

Volumn 64, Issue 3, 2011, Pages 455-472

  MacIas, Edgar S ^a   Pereira, Frederick A ^a,b   Rietkerk, William ^a   Safai, Bijan ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

bacterial toxins; Kawasaki disease; superantigens; toxic shock syndrome

Indexed keywords

SUPERANTIGEN;

ARTICLE; ATOPIC DERMATITIS; CUTANEOUS T CELL LYMPHOMA; DERMATOLOGY; ERYTHEMA; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; T LYMPHOCYTE ACTIVATION; TOXIC SHOCK SYNDROME;

EID: 79951562657     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.03.044     Document Type: Review

References (156)

1. P. Marrack, and J. Kappler The staphylococcal enterotoxins and their relatives Science 248 1990 705 711
2. D.Y. Leung, J.B. Travers, and D.A. Norris The role of superantigens in skin disease J Invest Dermatol 105 1 suppl 1995 37S 42S
3. B.L. Kotzin, D.Y. Leung, J. Kappler, and P. Marrack Superantigens and their potential role in human disease Adv Immunol 54 1993 99 166 (Pubitemid 23289252)
4. J.M. Yarwood, D.Y. Leung, and P.M. Schlievert Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome FEMS Microbiol Lett 192 2000 1 7
5. Y. Choi, J.A. Lafferty, J.R. Clements, J.K. Todd, E.W. Gelfand, and J. Kappler Selective expansion of T cells expressing V beta 2 in toxic shock syndrome J Exp Med 172 1990 981 984 (Pubitemid 20301247)
6. J. Saloga, and J. Knop Superantigens in skin diseases Eur J Dermatol 9 1999 586 590
7. M. Llewelyn, and J. Cohen Superantigens: microbial agents that corrupt immunity Lancet Infect Dis 2 2002 156 162 (Pubitemid 34462450)
8. D.Y. Leung, P. Hauk, I. Strickland, J.B. Travers, and D.A. Norris The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases Br J Dermatol 139 suppl 53 1998 17 29 (Pubitemid 29003262)
9. J.E. Alouf, and H. Muller-Alouf Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects Int J Med Microbiol 292 2003 429 440 (Pubitemid 36258454)
10. Z.J. Li, K. Omoe, K. Shinagawa, J. Yagi, and K. Imanishi Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases Microbiol Immunol 53 2009 451 459
11. M. Kotb, A. Norrby-Teglund, A. McGeer, K. Green, and D.E. Low Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience Scand J Infect Dis 35 2003 665 669 (Pubitemid 37336890)
12. A. Norrby-Teglund, S. Chatellier, D.E. Low, A. McGeer, K. Green, and M. Kotb Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection Eur J Immunol 30 2000 3247 3255
13. M. Kotb Bacterial pyrogenic exotoxins as superantigens Clin Microbiol Rev 8 1995 411 426
14. K. Imanishi, H. Igarashi, and T. Uchiyama Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B Infect Immun 60 1992 5025 5029
15. D.D. Taub, J.R. Newcomb, and T.J. Rogers Effect of isotypic and allotypic variations of MHC class II molecules on staphylococcal enterotoxin presentation to murine T cells Cell Immunol 141 1992 263 278
16. M. Kotb, A. Norby-Teglund, A. McGeer, J. Peeples, A. Khurshid, and Y. Guedez Distinct HLA haplotypes are associated with different outcomes of invasive streptococcal infections (abstr) Abstr Intersci Conf Antimicrob Agents Chemother 40 2000 62
17. M. Kotb Superantigens of Gram-positive bacteria: structure-function analyses and their implications for biological activity Curr Opin Microbiol 1 1998 56 65 (Pubitemid 128428043)
18. M. Kotb, A. Norrby-Teglund, A. McGeer, H. El-Sherbini, M.T. Dorak, and A. Khurshid An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections Nat Med 8 2002 1398 1404 (Pubitemid 36019425)
19. D.Y. Leung, M. Gately, A. Trumble, B. Ferguson-Darnell, P.M. Schlievert, and L.J. Picker Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production J Exp Med 181 1995 747 753
20. E. Lappin, and A.J. Ferguson Gram-positive toxic shock syndromes Lancet Infect Dis 9 2009 281 290
21. P.M. Schlievert, A.P. Assimacopoulos, and P.P. Cleary Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis J Lab Clin Med 127 1996 13 22
22. S. van Lierde, W.J. van Leeuwen, J. Ceuppens, L. Cornette, P. Goubau, and J. Van Eldere Toxic shock syndrome without rash in a young child: link with syndrome of hemorrhagic shock and encephalopathy? J Pediatr 131 1997 130 134 (Pubitemid 27498321)
23. K. Visvanathan, A. Charles, J. Bannan, P. Pugach, K. Kashfi, and J.B. Zabriskie Inhibition of bacterial superantigens by peptides and antibodies Infect Immun 69 2001 875 884 (Pubitemid 32109552)
24. E.H. Kass, M.I. Kendrick, Y.C. Tsai, and J. Parsonnet Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus J Infect Dis 155 1987 812 815
25. R.A. Ross, and A.B. Onderdonk Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide Infect Immun 68 2000 5205 5209
26. P.M. Schlievert, and D.A. Blomster Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors J Infect Dis 147 1983 236 242 (Pubitemid 13195102)
27. J.K. Todd, B.H. Todd, A. Franco-Buff, C.M. Smith, and D.W. Lawellin Influence of focal growth conditions on the pathogenesis of toxic shock syndrome J Infect Dis 155 1987 673 681 (Pubitemid 17052989)
28. K.N. Shands, G.P. Schmid, B.B. Dan, D. Blum, R.J. Guidotti, and N.T. Hargrett Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases N Engl J Med 303 1980 1436 1442
29. J.P. Davis, P.J. Chesney, P.J. Wand, and M. LaVenture Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention N Engl J Med 303 1980 1429 1435
30. M.S. Bergdoll, B.A. Crass, R.F. Reiser, R.N. Robbins, and J.P. Davis A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates Lancet 1 1981 1017 1021 (Pubitemid 11096622)
31. P.M. Schlievert, K.N. Shands, B.B. Dan, G.P. Schmid, and R.D. Nishimura Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome J Infect Dis 143 1981 509 516 (Pubitemid 11111260)
32. W.A. Altemeier, S.A. Lewis, P.M. Schlievert, M.S. Bergdoll, H.S. Bjornson, and J.L. Staneck Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing Ann Intern Med 96 1982 978 982 (Pubitemid 12088916)
33. M. Bergdoll, and P.M. Schlievert Toxic-shock syndrome toxin Lancet 2 1984 691
34. G.A. Bohach, D.J. Fast, R.D. Nelson, and P.M. Schlievert Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses Crit Rev Microbiol 17 1990 251 272 (Pubitemid 20249880)
35. E. Descloux, T. Perpoint, T. Ferry, G. Lina, M. Bes, and F. Vandenesch One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases Eur J Clin Microbiol Infect Dis 27 2008 37 43 (Pubitemid 350197878)
36. C.M. Herzer Toxic shock syndrome: broadening the differential diagnosis J Am Board Fam Pract 14 2001 131 136 (Pubitemid 33705688)
37. C.V. Broome Epidemiology of toxic shock syndrome in the United States: overview Rev Infect Dis 11 suppl 1 1989 S14 S21
38. A.E. Young, and K.L. Thornton Toxic shock syndrome in burns: diagnosis and management Arch Dis Child Educ Pract Ed 92 2007 ep97 100
39. F. Serour, M. Stein, A. Gorenstein, and E. Somekh Early burn related Gram positive systemic infection in children admitted to a pediatric surgical ward Burns 32 2006 352 356
40. M.C. White, K. Thornton, and A.E. Young Early diagnosis and treatment of toxic shock syndrome in paediatric burns Burns 31 2005 193 197 (Pubitemid 40430875)
41. M.R. Filbin, D.C. Ring, M.R. Wessels, L.L. Avery, and R.L. Kradin Case records of the Massachusetts General Hospital. Case 2-2009. A 25-year-old man with pain and swelling of the right hand and hypotension N Engl J Med 360 2009 281 290
42. H.Z. Lu, X.H. Weng, B. Zhu, H. Li, Y.K. Yin, and Y.X. Zhang Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis J Clin Microbiol 41 2003 3051 3055 (Pubitemid 36842300)
43. J.S. Bradley, P.M. Schlievert, and B.M. Peterson Toxic shock-like syndrome, a complication of strep throat Pediatr Infect Dis J 10 1991 790
44. Z. Vucicevic, I. Jajic-Bencic, B. Kruslin, and V. Degoricija Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in adults J Microbiol Immunol Infect 42 2009 276 279
45. J.D. Fraser, and T. Proft The bacterial superantigen and superantigen-like proteins Immunol Rev 225 2008 226 243
46. S. Sriskandan, L. Faulkner, and P. Hopkins Streptococcus pyogenes: insight into the function of the streptococcal superantigens Int J Biochem Cell Biol 39 2007 12 19 (Pubitemid 44548448)
47. M. Unnikrishnan, D.M. Altmann, T. Proft, F. Wahid, J. Cohen, and J.D. Fraser The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes J Immunol 169 2002 2561 2569 (Pubitemid 34921001)
48. D.L. Stevens, M.H. Tanner, J. Winship, R. Swarts, K.M. Ries, and P.M. Schlievert Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A N Engl J Med 321 1989 1 7 (Pubitemid 19170377)
49. T.L. Lamagni, J. Darenberg, B. Luca-Harari, T. Siljander, A. Efstratiou, and B. Henriques-Normark Epidemiology of severe Streptococcus pyogenes disease in Europe J Clin Microbiol 46 2008 2359 2367
50. S.J. Stolz, J.P. Davis, J.M. Vergeront, B.A. Crass, P.J. Chesney, and P.J. Wand Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin J Infect Dis 151 1985 883 889 (Pubitemid 15094607)
51. D.L. Stevens Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment Emerg Infect Dis 1 1995 69 78
52. J.M. Vergeront, S.J. Stolz, B.A. Crass, D.B. Nelson, J.P. Davis, and M.S. Bergdoll Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome J Infect Dis 148 1983 692 698 (Pubitemid 13021673)
53. H. Basma, A. Norrby-Teglund, Y. Guedez, A. McGeer, D.E. Low, and O. El-Ahmedy Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity Infect Immun 67 1999 1871 1877 (Pubitemid 29144409)
54. B.K. Eriksson, J. Andersson, S.E. Holm, and M. Norgren Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome J Infect Dis 180 1999 410 418 (Pubitemid 30256323)
55. + T cell responses: the alternative approaches Annu Rev Immunol 15 1997 297 322 (Pubitemid 27169283)
56. M.F. Hofer, K. Newell, R.C. Duke, P.M. Schlievert, J.H. Freed, and D.Y. Leung Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis Proc Natl Acad Sci U S A 93 1996 5425 5430 (Pubitemid 26159466)
57. E.A. Coyle, R. Cha, and M.J. Rybak Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release Antimicrob Agents Chemother 47 2003 1752 1755 (Pubitemid 36548568)
58. N. Takahashi Neonatal toxic shock syndrome-like exanthematous disease (NTED) Pediatr Int 45 2003 233 237 (Pubitemid 36578954)
59. N. Takahashi, H. Kato, K. Imanishi, K. Miwa, S. Yamanami, and H. Nishida Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen J Clin Invest 106 2000 1409 1415
60. L.C. Hughey Fever and erythema in the emergency room Semin Cutan Med Surg 26 2007 133 138 (Pubitemid 350216504)
61. A. Verbon, and C.J. Fisher Jr. Severe recalcitrant erythematous desquamating disorder associated with fatal recurrent toxic shock syndrome in a patient without AIDS Clin Infect Dis 24 1997 1274 1275 (Pubitemid 27249048)
62. L.A. Cone, D.R. Woodard, R.G. Byrd, K. Schulz, S.M. Kopp, and P.M. Schlievert A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS J Infect Dis 165 1992 638 643
63. T. Yoshioka, T. Matsutani, T. Toyosaki-Maeda, H. Suzuki, S. Uemura, and R. Suzuki Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease Pediatr Res 53 2003 403 410 (Pubitemid 36237394)
64. K. Stankovic, P. Miailhes, D. Bessis, T. Ferry, C. Broussolle, and P. Seve Kawasaki-like syndromes in HIV-infected adults J Infect 55 2007 488 494 (Pubitemid 350082474)
65. K.A. Taubert, A.H. Rowley, and S.T. Shulman Seven-year national survey of Kawasaki disease and acute rheumatic fever Pediatr Infect Dis J 13 1994 704 708 (Pubitemid 24266880)
66. M.S. Anderson, J.K. Todd, and M.P. Glode Delayed diagnosis of Kawasaki syndrome: an analysis of the problem Pediatrics 115 2005 e428 e433
67. S. D'Souza, R.P. Khubchandani, and A.K. Shetty Kawasaki disease presenting with hemorrhagic pleural effusion J Trop Pediatr 52 2006 299 301 (Pubitemid 44304897)
68. M.M. Tiao, L.T. Huang, C.D. Liang, and S.F. Ko Atypical Kawasaki disease presenting as intestinal pseudo-obstruction J Formos Med Assoc 105 2006 252 255
69. K.E. Elizabeth, M.Z. Ahamed, and K.S. Praveen Atypical relapsing course of Kawasaki disease with hemorrhagic serous effusions and hepatic dysfunction Indian Pediatr 44 2007 785 787 (Pubitemid 350021510)
70. P. Valentini, E. Ausili, A. Schiavino, D.F. Angelone, B. Focarelli, and G. De Rosa Acute cholestasis: atypical onset of Kawasaki disease Dig Liver Dis 40 2008 582 584 (Pubitemid 351796695)
71. E.W. Langley, D.K. Kirse, C.E. Barnes, W. Covitz, and A.K. Shetty Retropharyngeal edema: an unusual manifestation of Kawasaki disease J Emerg Med 39 2010 181 185
72. S.A. Papadodima, E.I. Sakelliadis, N.D. Goutas, D.G. Vlachodimitropoulos, and C.A. Spiliopoulou Atypical Kawasaki disease presenting with symptoms from the genitourinary system: an autopsy report J Trop Pediatr 55 2009 55 57
73. Y.C. Hsieh, M.H. Wu, J.K. Wang, P.I. Lee, C.Y. Lee, and L.M. Huang Clinical features of atypical Kawasaki disease J Microbiol Immunol Infect 35 2002 57 60
74. S.J. Popper, C. Shimizu, H. Shike, J.T. Kanegaye, J.W. Newburger, and R.P. Sundel Gene-expression patterns reveal underlying biological processes in Kawasaki disease Genome Biol 8 2007 R261
75. H.C. Meissner, and D.Y. Leung Superantigens, conventional antigens and the etiology of Kawasaki syndrome Pediatr Infect Dis J 19 2000 91 94 (Pubitemid 30111401)
76. S.R. Dominguez, K. Friedman, R. Seewald, M.S. Anderson, L. Willis, and M.P. Glode Kawasaki disease in a pediatric intensive care unit: a case-control study Pediatrics 122 2008 e786 e790
77. M.A. Yamazaki-Nakashimada, M. Espinosa-Lopez, V. Hernandez-Bautista, S. Espinosa-Padilla, and F. Espinosa-Rosales Catastrophic Kawasaki disease or juvenile polyarteritis nodosa? Semin Arthritis Rheum 35 2006 349 354 (Pubitemid 43831157)
78. B.A. Eberhard, R.P. Sundel, J.W. Newburger, A. Baker, R.C. Fuhlbrigge, and J.C. Burns Psoriatic eruption in Kawasaki disease J Pediatr 137 2000 578 580
79. C.L. Brosius, J.W. Newburger, J.C. Burns, P. Hojnowski-Diaz, S. Zierler, and D.Y. Leung Increased prevalence of atopic dermatitis in Kawasaki disease Pediatr Infect Dis J 7 1988 863 866 (Pubitemid 19015291)
80. D.Y. Leung, H.C. Meissner, D.R. Fulton, D.L. Murray, B.L. Kotzin, and P.M. Schlievert Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome Lancet 342 1993 1385 1388 (Pubitemid 23361239)
81. D.Y. Leung, H.C. Meissner, S.T. Shulman, W.H. Mason, M.A. Gerber, and M.P. Glode Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease J Pediatr 140 2002 742 746 (Pubitemid 34666695)
82. S.M. Benseler, B.W. McCrindle, E.D. Silverman, P.N. Tyrrell, J. Wong, and R.S. Yeung Infections and Kawasaki disease: implications for coronary artery outcome Pediatrics 116 2005 e760 e766
83. B.S. Friter, and A.W. Lucky The perineal eruption of Kawasaki syndrome Arch Dermatol 124 1988 1805 1810 (Pubitemid 19010099)
84. Y. Yamashiro, S. Nagata, S. Oguchi, and T. Shimizu Selective increase of V beta 2+ T cells in the small intestinal mucosa in Kawasaki disease Pediatr Res 39 1996 264 266 (Pubitemid 26039549)
85. P.A. Brogan, V. Shah, L.A. Clarke, M.J. Dillon, and N. Klein T cell activation profiles in Kawasaki syndrome Clin Exp Immunol 151 2008 267 274
86. P.A. Brogan, V. Shah, N. Klein, and M.J. Dillon Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury Arthritis Rheum 50 2004 589 597 (Pubitemid 38202231)
87. K. Matsubara, and T. Fukaya The role of superantigens of group A streptococcus and Staphylococcus aureus in Kawasaki disease Curr Opin Infect Dis 20 2007 298 303 (Pubitemid 46686013)
88. K. Matsubara, T. Fukaya, K. Miwa, N. Shibayama, H. Nigami, and H. Harigaya Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease Clin Exp Immunol 143 2006 427 434
89. S. Nagata, Y. Yamashiro, M. Maeda, Y. Ohtsuka, and K. Yabuta Immunohistochemical studies on small intestinal mucosa in Kawasaki disease Pediatr Res 33 1993 557 563 (Pubitemid 23159449)
90. T. Suenaga, H. Suzuki, S. Shibuta, T. Takeuchi, and N. Yoshikawa Detection of multiple superantigen genes in stools of patients with Kawasaki disease J Pediatr 155 2009 266 270
91. H.C. Meissner, and D.Y. Leung Kawasaki syndrome: where are the answers? Pediatrics 112 2003 672 676 (Pubitemid 37082124)
92. P. Sve, K. Stankovic, A. Smail, D.V. Durand, G. Marchand, and C. Broussolle Adult Kawasaki disease: report of two cases and literature review Semin Arthritis Rheum 34 2005 785 792 (Pubitemid 40732453)
93. R.M. Johnson, J.R. Little, and G.A. Storch Kawasaki-like syndromes associated with human immunodeficiency virus infection Clin Infect Dis 32 2001 1628 1634 (Pubitemid 32458732)
94. R.M. Johnson, G. Barbarini, and G. Barbaro Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients AIDS 17 suppl 1 2003 S77 S82
95. J.N. Blanchard, H.C. Powell, W.R. Freeman, S. Letendre, D. Blanchard, and C. Shimizu Recurrent Kawasaki disease-like syndrome in a patient with acquired immunodeficiency syndrome Clin Infect Dis 36 2003 105 111 (Pubitemid 36099105)
96. Y. Tokura, P.W. Heald, S.L. Yan, and R.L. Edelson Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins J Invest Dermatol 98 1992 33 37
97. Y. Tokura, H. Yagi, A. Ohshima, S. Kurokawa, H. Wakita, and R. Yokote Cutaneous colonization with staphylococci influences the disease activity of Sezary syndrome: a potential role for bacterial superantigens Br J Dermatol 133 1995 6 12
98. S. Sano, Y. Matsui, S. Itami, and K. Yoshikawa Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome Clin Exp Immunol 113 1998 190 197 (Pubitemid 28352836)
99. T. Linnemann, S. Gellrich, A. Lukowsky, A. Mielke, H. Audring, and W. Sterry Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma: evidence for possible superantigen involvement Br J Dermatol 150 2004 1013 1017 (Pubitemid 38903539)
100. N. Yawalkar, K. Ferenczi, D.A. Jones, K. Yamanaka, K.Y. Suh, and S. Sadat Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma Blood 102 2003 4059 4066 (Pubitemid 37486989)
101. K. Yamanaka, N. Yawalkar, D.A. Jones, D. Hurwitz, K. Ferenczi, and S. Eapen Decreased T-cell receptor excision circles in cutaneous T-cell lymphoma Clin Cancer Res 11 2005 5748 5755 (Pubitemid 41170299)
102. C.M. Jackow, J.C. Cather, V. Hearne, A.T. Asano, J.M. Musser, and M. Duvic Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion Blood 89 1997 32 40 (Pubitemid 26428175)
103. R. Talpur, R. Bassett, and M. Duvic Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome Br J Dermatol 159 2008 105 112 (Pubitemid 351874496)
104. A. Asarch, O. Barak, D.S. Loo, and A.B. Gottlieb Th17 cells: a new paradigm for cutaneous inflammation J Dermatolog Treat 19 2008 259 266
105. K. Eyerich, D. Pennino, C. Scarponi, S. Foerster, F. Nasorri, and H. Behrendt IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response J Allergy Clin Immunol 123 2009 59 66 e4
106. I. Brownell Sexy and 17: TH17 effector T cells and psoriasis J Drugs Dermatol 6 2007 853 856
107. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 Cells Ann Rev Immunol 27 2009 485 517
108. D.Y. Leung, J.B. Travers, R. Giorno, D.A. Norris, R. Skinner, and J. Aelion Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis J Clin Invest 96 1995 2106 2112
109. G. Zhao, X. Feng, A. Na, J. Yongqiang, Q. Cai, and J. Kong Acute guttate psoriasis patients have positive streptococcus hemolyticus throat cultures and elevated antistreptococcal M6 protein titers J Dermatol 32 2005 91 96 (Pubitemid 40410297)
110. N.R. Telfer, R.J. Chalmers, K. Whale, and G. Colman The role of streptococcal infection in the initiation of guttate psoriasis Arch Dermatol 128 1992 39 42
111. B.A. Martin, R.J. Chalmers, and N.R. Telfer How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol 132 1996 717 718 (Pubitemid 26174124)
112. P. Strange, K.D. Cooper, E.R. Hansen, G. Fisher, J.K. Larsen, and D. Fox T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation J Invest Dermatol 101 1993 695 700 (Pubitemid 23322026)
113. H. Valdimarsson, B.S. Baker, I. Jonsdottir, A. Powles, and L. Fry Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16 1995 145 149
114. T. Wrone-Smith, and B.J. Nickoloff Dermal injection of immunocytes induces psoriasis J Clin Invest 98 1996 1878 1887 (Pubitemid 26359206)
115. W.H. Boehncke, D. Dressel, T.M. Zollner, and R. Kaufmann Pulling the trigger on psoriasis Nature 379 1996 777
116. H.J. Whyte, and R.D. Baughman Acute guttate psoriasis and streptococcal Infection Arch Dermatol 89 1964 350 356
117. C.A. Henderson, and A.S. Highet Acute psoriasis associated with Lancefield group C and group G cutaneous streptococcal infections Br J Dermatol 118 1988 559 562
118. D.Y. Leung, H.C. Meissner, D.R. Fulton, F. Quimby, and P.M. Schlievert Superantigens in Kawasaki syndrome Clin Immunol Immunopathol 77 1995 119 126
119. H.M. Lewis, B.S. Baker, S. Bokth, A.V. Powles, J.J. Garioch, and H. Valdimarsson Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis Br J Dermatol 129 1993 514 520 (Pubitemid 23336445)
120. J. McFadden, H. Valdimarsson, and L. Fry Cross-reactivity between streptococcal M surface antigen and human skin Br J Dermatol 125 1991 443 447
121. N.S. Tomi, B. Kranke, and E. Aberer Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects J Am Acad Dermatol 53 2005 67 72 (Pubitemid 40826696)
122. D.D. Balci, N. Duran, B. Ozer, R. Gunesacar, Y. Onlen, and J.Z. Yenin High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis Eur J Dermatol 19 2009 238 242
123. D.Y. Leung Atopic dermatitis: new insights and opportunities for therapeutic intervention J Allergy Clin Immunol 105 2000 860 876 (Pubitemid 30324392)
124. A. Asarch, O. Barak, D.S. Loo, and A.B. Gottlieb Th17 cells: a new therapeutic target in inflammatory dermatoses J Dermatolog Treat 19 2008 318 326
125. U. Islander, A. Andersson, E. Lindberg, I. Adlerberth, A.E. Wold, and A. Rudin Superantigenic Staphylococcus aureus stimulates production of interleukin-17 from memory but not naive T cells Infect Immun 78 2010 381 386
126. L.F. Wang, H.C. Chiu, C.J. Hsu, C.Y. Liu, Y.H. Hsueh, and S.C. Miaw Epicutaneous sensitization with a protein antigen induces Th17 cells J Dermatolog Sci 54 2009 192 197
127. P. Strange, L. Skov, S. Lisby, P.L. Nielsen, and O. Baadsgaard Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis Arch Dermatol 132 1996 27 33 (Pubitemid 26024807)
128. Y.W. Choi, B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler Interaction of Staphylococcus aureus toxin "superantigens" with human T cells Proc Natl Acad Sci U S A 86 1989 8941 8945 (Pubitemid 20010341)
129. R. Bunikowski, M.E. Mielke, H. Skarabis, M. Worm, I. Anagnostopoulos, and G. Kolde Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis J Allergy Clin Immunol 105 2000 814 819 (Pubitemid 30226458)
130. R. Lever, K. Hadley, D. Downey, and R. Mackie Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy Br J Dermatol 119 1988 189 198
131. M. Yoshimura-Mishima, H. Akamatsu, S. Namura, and T. Horio Suppressive effect of ultraviolet (UVB and PUVA) radiation on superantigen production by Staphylococcus aureus J Dermatolog Sci 19 1999 31 36 (Pubitemid 28552868)
132. Y.T. Lin, W.Y. Shau, L.F. Wang, Y.H. Yang, Y.W. Hwang, and M.J. Tsai Comparison of serum specific IgE antibodies to staphylococcal enterotoxins between atopic children with and without atopic dermatitis Allergy 55 2000 641 646 (Pubitemid 30438997)
133. M.O. Taskapan, and P. Kumar Role of staphylococcal superantigens in atopic dermatitis: from colonization to inflammation Ann Allergy Asthma Immunol 84 2000 3 10
134. R. Bunikowski, M. Mielke, H. Skarabis, U. Herz, R.L. Bergmann, and U. Wahn Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis J Allergy Clin Immunol 103 1999 119 124 (Pubitemid 29063201)
135. A. Tripathi, D.B. Conley, L.C. Grammer, A.M. Ditto, M.M. Lowery, and K.A. Seiberling Immunoglobulin E to staphylococcal and streptococcal toxins in patients with chronic sinusitis/nasal polyposis Laryngoscope 114 2004 1822 1826 (Pubitemid 39332262)
136. A. Hill, M. Hanson, M.A. Bogle, and M. Duvic Severe radiation dermatitis is related to Staphylococcus aureus Am J Clin Oncol 27 2004 361 363 (Pubitemid 39045245)
137. S.M. Manders, W.R. Heymann, E. Atillasoy, J. Kleeman, and P.M. Schlievert Recurrent toxin-mediated perineal erythema Arch Dermatol 132 1996 57 60 (Pubitemid 26024811)
138. A. Patrizi, B. Raone, F. Savoia, G. Ricci, and I. Neri Recurrent toxin-mediated perineal erythema: eleven pediatric cases Arch Dermatol 144 2008 239 243 (Pubitemid 351287008)
139. S.M. Manders Toxin-mediated streptococcal and staphylococcal disease J Am Acad Dermatol 39 1998 383 398 (Pubitemid 28417372)
140. M. Braun-Falco, A. Kasche, and W.I. Worret Recurring localized scarlatiniform scaled erythema Féréol-Besnier Dermatology 212 2006 253 257
141. M. Landthaler, M. Michalopoulos, U. Schwab, and M. Dorn Erythema scarlatiniforme desquamativum recidivans localisatum [in German] Hautarzt 36 1985 581 585 (Pubitemid 15248057)
142. R. Herbst Perineal streptococcal dermatitis/disease: recognition and management Am J Clin Dermatol 4 2003 555 560 (Pubitemid 36995077)
143. A. Velez, and J.C. Moreno Febrile perianal streptococcal dermatitis Pediatr Dermatol 16 1999 23 24 (Pubitemid 29102627)
144. A. Patrizi, A.M. Costa, L. Fiorillo, and I. Neri Perianal streptococcal dermatitis associated with guttate psoriasis and/or balanoposthitis: a study of five cases Pediatr Dermatol 11 1994 168 171 (Pubitemid 24174288)
145. M. Amagai, N. Matsuyoshi, Z.H. Wang, C. Andl, and J.R. Stanley Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1 Nat Med 6 2000 1275 1277
146. L.R. Plano, D.M. Gutman, M. Woischnik, and C.M. Collins Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens Infection Immun 68 2000 3048 3052 (Pubitemid 30253896)
147. B. Fleischer, and C.J. Bailey Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen Med Microbiol Immunol 180 1992 273 278
148. B. Fleischer Too many superantigens J. Thibodeau, R-P. Sekaly, Bacterial superantigens: structure function and therapeutic potential 1995 R.G. Landes Company Austin p. 25-38
149. F. Niedergang, A. Hemar, C.R. Hewitt, M.J. Owen, A. Dautry-Varsat, and A. Alcover The Staphylococcus aureus enterotoxin B superantigen induces specific T cell receptor down-regulation by increasing its internalization J Biol Chem 270 1995 12839 12845
150. S.R. Monday, G.M. Vath, W.A. Ferens, C. Deobald, J.V. Rago, and P.J. Gahr Unique superantigen activity of staphylococcal exfoliative toxins J Immunol 162 1999 4550 4559 (Pubitemid 29314854)
151. J. White, A. Herman, A.M. Pullen, R. Kubo, J.W. Kappler, and P. Marrack The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice Cell 56 1989 27 35 (Pubitemid 19033513)
152. F. Furukawa, Y. Tokura, K. Matsushita, K. Iwasaki-Inuzuka, K. Onagi-Suzuki, and H. Yagi Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus J Dermatol 23 1996 670 676 (Pubitemid 26396726)
153. E.R. Popa, C.A. Stegeman, W.H. Abdulahad, B. van der Meer, J. Arends, and W.M. Manson Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis Rheumatology (Oxford) 46 2007 1029 1033 (Pubitemid 47062516)
154. R.H. Deurenberg, R.F. Nieuwenhuis, C. Driessen, N. London, F.R. Stassen, and F.H. van Tiel The prevalence of the Staphylococcus aureus tst gene among community- and hospital-acquired strains and isolates from Wegener's granulomatosis patients FEMS Microbiol Lett 245 2005 185 189 (Pubitemid 40410693)
155. E.R. Popa, C.A. Stegeman, N.A. Bos, C.G. Kallenberg, and J.W. Tervaert Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis Clin Exp Immunol 132 2003 496 504 (Pubitemid 36713957)
156. E.R. Popa, C.A. Stegeman, C.G. Kallenberg, and J.W. Tervaert Staphylococcus aureus and Wegener's granulomatosis Arthritis Res 4 2002 77 79